Continue increasing by 0.25 to 0.5 mg every 4 weeks until reaching the target dose or maximum tolerated dose
Clinical research demonstrated that AOD-9604 does not elevate IGF-1 levels, which distinguishes it from other fat loss peptides
Kraus D, Yang Q, Kong D, et al
It is the most bioavailable form of B12, and also the most active, working mostly in our brains, nervous system, and liver (Lindstrand, 1964)
Underlying health conditions: Some health conditions, such as gastrointestinal disorders or liver disease, can affect B12 absorption and metabolism, potentially leading to shorter-lasting benefits from B12 injections
Some health problems can make it hard for the body to take in vitamin B12